パクリタキセルの後発医薬品間の製剤学的特性および治療学的 安全性の比較

DOI Web Site

書誌事項

タイトル別名
  • Comparison of Formulation Property and Therapeutic Safety of Paclitaxel between Generic Products
  • パクリタキセル ノ コウハツ イヤクヒン カン ノ セイザイガクテキ トクセイ オヨビ チリョウガクテキ アンゼンセイ ノ ヒカク

この論文をさがす

抄録

Background: Because generic medicines reduce the financial burden on patients and medical insurance providers, they become more popular year after year.  However, there are still few reports that analyze the efficacy and safety of generic medicines, especially in terms of their characteristics and side effects.<br>Methods: Paclitaxel is an antineoplastic frequently used with good results in the treatment of breast cancer, ovarian cancer, gastric cancer, and angiosarcoma, but fat solubility is high and various kinds of adverse events, such as myelosuppression and arthralgia, peripheral neuropathy, and alcohol hypersensitivity are known to develop.  We investigated the efficacy, characteristics, and the incidence of adverse events for the generic product of paclitaxel.<br>Results: Differences were found for the generic version in terms of the characteristics and preparation time.<br>Conclusion: The incidence of adverse events was not significant, suggesting that the generic version could be a reasonable substitute.

収録刊行物

  • 医薬品情報学

    医薬品情報学 18 (1), 7-12, 2016

    一般社団法人　日本医薬品情報学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ